InvestorsHub Logo
Post# of 4979302
Next 10
Followers 1523
Posts 89305
Boards Moderated 5
Alias Born 05/09/2004

Re: sharky post# 4886613

Friday, 06/10/2022 12:43:48 PM

Friday, June 10, 2022 12:43:48 PM

Post# of 4979302
The MEDICAL COMPANIES that will be at the JMP EVENT NEXT WEEK below

"JMP Securities’ sales and trading platform serves a broad institutional client base."
https://www.jmpg.com/jmp-securities/sales-trading

KTRA and AEZS being (by far) less in price than the rest and KTRA expected to have a PHASE 2 ANNOUNCEMENT COMING

"Phase 2 Study of VAL-083 Treatment for MGMT Unmethylated Bevacizumab-naïve Glioblastoma in the Adjuvant or Recurrent Setting

Estimated Primary Completion Date
June 2022"

https://www.kintaraclinicaltrials.com/our-trials/brain-tumor-trials/for-patients-with-mgmt-unmethylated-bevacizumab-naive-recurrent-glioblastoma

OS - 65,532,826 - 05/11/2022
https://www.otcmarkets.com/stock/KTRA/security

We could see a BIG MOVE UPWARDS into the DOLLAR+ RANGE. Imo

https://jmp-ls.ljfevents-rsvp.com/participating-companies
ATNM AEZS ALT AMTI APYX AQST ABUS AVRO AXGN BCRX BWV BPMC CSTL CLLS CMMB CLSD CLNN CGTX CGEN CNCE CRMD CRNX CTIC CUE CVAC CYTK DBVT DCPH EFTR ENTA NDRA FENC FNCH GMDA HOOK BIO ICAD ICCM IMUX IMPL INDP IART IOVA KMPH KTRA KURA LBPH MGNX MDGL MRSN MORF MOR NXTC KIDS OXUR
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.